Pen­ny stock, Mer­ck part­ner lays off 45% of staff to reach PhII read­out by ear­ly 2023

An­oth­er biotech is feel­ing the chill of the bear mar­ket, lay­ing off staff in an ef­fort to pre­serve cash.

Can­cer im­munother­a­py start­up On­coSec Med­ical an­nounced …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER